Genetically Encoded CB2R-Based Fluorescent Sensor Enables Rapid Screening and Functional Assessment of Cannabinoid Modulators
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27052095 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Pinaki Bhattacharjee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD 2…. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB2, Cannabinoids, Biosensing Techniques, Cannabinoid Receptor Modulators. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Abstract (Originalsprache)
The G-protein-coupled receptor cannabinoid receptor 2 (CB2R) initiates a key signaling pathway in mammalian physiology and pathophysiology. CB2R signaling holds significant therapeutic potential in ameliorating many pathologies, particularly in inflammatory conditions, neurodegenerative disorders, fibroproliferative and ocular diseases. CB2 modulators have been studied for their anti-inflammatory and tissue protective effects in preclinical animal models of cardiovascular, gastrointestinal, liver, kidney, lung and neurodegenerative disorders with numerous compounds undergoing clinical evaluation. Existing ligands can be classified as endocannabinoids, cannabinoid-like natural products and synthetic CB2R ligands. A genetically encoded G-protein-coupled receptor activation-based (GRAB) sensor for CB1R—GRABeCB2.0 was developed recently. This current study extends the sensor’s development to allow for a GPCR activation-based sensor for CB2R. The sensor, GRAB-CB2, will facilitate the evaluation of pharmacological characteristics and responses of various functionally selective and indiscriminate cannabinoid ligands acting on CB2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD 20852, USA.
- Laboratory of Biophotonics and Quantum Biology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD 20852, USA.
ORCID-Profile: Pinaki Bhattacharjee, Samay Shivshankar, Henry Puhl, Malliga R Iyer
Förderung
- NIAAA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Bhattacharjee, P., Volesky, P. D., Shivshankar, S., Puhl, H., & Iyer, M. R. (2026). Genetically Encoded CB2R-Based Fluorescent Sensor Enables Rapid Screening and Functional Assessment of Cannabinoid Modulators. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052095
Vancouver
Bhattacharjee P, Volesky PD, Shivshankar S, Puhl H, Iyer MR. Genetically Encoded CB2R-Based Fluorescent Sensor Enables Rapid Screening and Functional Assessment of Cannabinoid Modulators. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052095
BibTeX
@article{Bhattacharjee2026,
author = {Bhattacharjee, Pinaki and Volesky, Paul D and Shivshankar, Samay and Puhl, Henry and Iyer, Malliga R},
title = {Genetically Encoded CB2R-Based Fluorescent Sensor Enables Rapid Screening and Functional Assessment of Cannabinoid Modulators},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27052095}
}
EUVIMED